跳至主要内容
临床试验/RBR-9b7jbxm
RBR-9b7jbxm终止未知

Randomized, pilot, multicenter clinical study in Brazil to assess the feasibility ofimprovement of static lung compliance by different PEEP Titration Methods in patients with ARDS - PEEP ARDS Positive End Expiratory PressureAdult Respiratory Distress Syndrome

Hospital Nereu Ramos0 个研究点开始时间: 2022年12月30日最近更新:

试验速览

阶段
未知
状态
终止
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
18Y 至 0(—)

入选标准

  • Intubated patients of both gender with mechanical ventilation; ARDS Berlin Criteria with less than 72 hours; older than 18 years old

排除标准

  • High dose of vasoactive drugs; Intracranial hypertension; Patients with acute myocardial infarction; Presence of pneumothorax, subcutaneous emphysema, pneumomediastinum, or pneumatocele; Paliative care exclusive patients; Severe thoracic trauma and/or thorax drainage; Patients with pacemaker or automatic desfibrilators

研究者

发起方
Hospital Nereu Ramos

相似试验

已完成
不适用
Randomised, controlled, multicenter, pilot study comparing qigong and back school for elderly patients with chronic neck pai
ISRCTN77101807Charité - University Medicine Berlin (Charité - Universitätsmedizin Berlin) (Germany)120
进行中(未招募)
1 期
A clinical study investigating the efficacy, tolerability and safety of brexpiprazole for the acute treatment of manic episodes, with or without mixed features, in subjects with a diagnosis of bipolar I disorder
EUCTR2017-002190-20-HROtsuka Pharmaceutical Development & Commercialization, Inc.333
进行中(未招募)
1 期
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole versus Placebo for the Acute Treatment of Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
EUCTR2017-002222-20-PLOtsuka Pharmaceutical Development & Commercialization, Inc.322
进行中(未招募)
1 期
A clinical study investigating the efficacy, tolerability and safety of brexpiprazole for the acute treatment of manic episodes, with or without mixed features, in subjects with a diagnosis of bipolar I disorderTreatment of Manic Episodes Associated with Bipolar I DisorderMedDRA version: 20.0Level: LLTClassification code 10068455Term: Bipolar I disorder, hypomanicSystem Organ Class: 100000004873
EUCTR2017-002222-20-BGOtsuka Pharmaceutical Development & Commercialization, Inc.322
已完成
不适用
A multi-centre, randomised, controlled trial of bronchoalveolar lavage (BAL) directed therapy in young children with cystic fibrosis (CF).Human Genetics and Inherited Disorders - Cystic fibrosisCystic Fibrosis
ACTRN12605000665639HMRC165